Format

Send to

Choose Destination
See comment in PubMed Commons below
Arch Neurol. 2009 Aug;66(8):933-8. doi: 10.1001/archneurol.2009.180.

Progress and challenges in RNA interference therapy for Huntington disease.

Author information

1
Department of Pediatrics, The Ohio State University Medical Center, and Center for Gene Therapy, The Research Institute at Nationwide Children's Hospital, 700 Children's Dr, Room WA2015, Columbus, OH 43205, USA. harper.104@osu.edu

Erratum in

  • Arch Neurol. 2009 Oct;66(10):1272.

Abstract

Huntington disease is an incurable, dominant neurodegenerative disorder caused by polyglutamine repeat expansion in the huntingtin protein. Reducing mutant huntingtin expression may offer a treatment for Huntington disease. RNA interference has emerged as a powerful method to silence dominant disease genes. As such, it is being developed as a prospective Huntington disease therapy. Here I discuss the current progress and important remaining challenges of RNA interference therapy for Huntington disease.

PMID:
19667213
DOI:
10.1001/archneurol.2009.180
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems
    Loading ...
    Support Center